2cn5
From Proteopedia
Line 1: | Line 1: | ||
[[Image:2cn5.gif|left|200px]] | [[Image:2cn5.gif|left|200px]] | ||
- | + | <!-- | |
- | + | The line below this paragraph, containing "STRUCTURE_2cn5", creates the "Structure Box" on the page. | |
- | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
- | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
- | + | or leave the SCENE parameter empty for the default display. | |
- | | | + | --> |
- | | | + | {{STRUCTURE_2cn5| PDB=2cn5 | SCENE= }} |
- | + | ||
- | + | ||
- | }} | + | |
'''CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP''' | '''CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP''' | ||
Line 28: | Line 25: | ||
[[Category: Oliver, A W.]] | [[Category: Oliver, A W.]] | ||
[[Category: Pearl, L H.]] | [[Category: Pearl, L H.]] | ||
- | [[Category: | + | [[Category: Activation segment]] |
- | [[Category: | + | [[Category: Alternative splicing]] |
- | [[Category: | + | [[Category: Atp-binding]] |
- | [[Category: | + | [[Category: Cancer]] |
- | [[Category: | + | [[Category: Cds1]] |
- | [[Category: | + | [[Category: Cell cycle]] |
- | [[Category: | + | [[Category: Checkpoint]] |
- | [[Category: | + | [[Category: Chek2]] |
- | [[Category: | + | [[Category: Chk2]] |
- | [[Category: | + | [[Category: Disease mutation]] |
- | [[Category: | + | [[Category: Kinase]] |
- | [[Category: | + | [[Category: Kinase domain]] |
- | [[Category: | + | [[Category: Li-fraumeni syndrome]] |
- | [[Category: | + | [[Category: Magnesium]] |
- | [[Category: | + | [[Category: Metal-binding]] |
- | [[Category: | + | [[Category: Nuclear protein]] |
- | [[Category: | + | [[Category: Nucleotide-binding]] |
- | [[Category: | + | [[Category: Phosphorylation]] |
- | [[Category: | + | [[Category: Proto-oncogene]] |
- | [[Category: | + | [[Category: Rad53]] |
- | [[Category: | + | [[Category: Serine/threonine-protein kinase]] |
- | [[Category: | + | [[Category: Transferase]] |
- | [[Category: | + | [[Category: Tumour suppressor]] |
- | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 22:33:53 2008'' | |
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + |
Revision as of 19:33, 3 May 2008
CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP
Overview
The protein kinase Chk2 (checkpoint kinase 2) is a major effector of the replication checkpoint. Chk2 activation is initiated by phosphorylation of Thr68, in the serine-glutamine/threonine-glutamine cluster domain (SCD), by ATM. The phosphorylated SCD-segment binds to the FHA domain of a second Chk2 molecule, promoting dimerisation of the protein and triggering phosphorylation of the activation segment/T-loop in the kinase domain. We have now determined the structure of the kinase domain of human Chk2 in complexes with ADP and a small-molecule inhibitor debromohymenialdisine. The structure reveals a remarkable dimeric arrangement in which T-loops are exchanged between protomers, to form an active kinase conformation in trans. Biochemical data suggest that this dimer is the biologically active state promoted by ATM-phosphorylation, and also suggests a mechanism for dimerisation-driven activation of Chk2 by trans-phosphorylation.
About this Structure
2CN5 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange., Oliver AW, Paul A, Boxall KJ, Barrie SE, Aherne GW, Garrett MD, Mittnacht S, Pearl LH, EMBO J. 2006 Jul 12;25(13):3179-90. Epub 2006 Jun 22. PMID:16794575 Page seeded by OCA on Sat May 3 22:33:53 2008
Categories: Homo sapiens | Non-specific serine/threonine protein kinase | Single protein | Oliver, A W. | Pearl, L H. | Activation segment | Alternative splicing | Atp-binding | Cancer | Cds1 | Cell cycle | Checkpoint | Chek2 | Chk2 | Disease mutation | Kinase | Kinase domain | Li-fraumeni syndrome | Magnesium | Metal-binding | Nuclear protein | Nucleotide-binding | Phosphorylation | Proto-oncogene | Rad53 | Serine/threonine-protein kinase | Transferase | Tumour suppressor